Regulatory Clarity Across Continents

---

Global Bridge crafts tailored regulatory strategies that align with country-specific requirements while leveraging global harmonization opportunities. From early development through post-marketing, Global Bridge helps sponsors anticipate challenges, align clinical timelines with regulatory milestones, and build submission plans that accelerate approvals across North America, Europe, and Asia Pacific.

Global Bridge supports the end-to-end preparation and submission of clinical trial applications (CTAs, INDs, IMPDs) and amendments. Our team ensures regulatory documents are complete, compliant, and tailored to each region’s format and expectations, reducing the risk of queries and delays from agencies such as FDA, EMA, MHRA, and PMDA.

Global Bridge provides up-to-date regulatory intelligence, tracking evolving guidance and country-specific updates to keep sponsors ahead of compliance changes. Through strategic gap analysis, Global Bridge identifies documentation or procedural weaknesses that could hinder approval - empowering sponsors to proactively address risks before submission.

Global Bridge offers expert medical writers and regulatory professionals who author, review, and QC high-quality regulatory documents including Investigator’s Brochures, Clinical Protocols, Module 2 and 3 summaries, and briefing packages. Our attention to clarity, consistency, and format helps ensure agency-ready submissions that reflect scientific and regulatory excellence.

Global Bridge supports clients in planning and executing successful regulatory interactions - from pre-IND and Scientific Advice meetings to Type B and Type C engagements. Our services include meeting strategy, question framing, briefing document preparation, and mock meeting rehearsals to ensure impactful and productive dialogues with regulators.

Beyond trial initiation, Global Bridge offers ongoing support for protocol amendments, annual reports, and safety reporting obligations. Our team ensures timely submissions, tracks evolving obligations, and maintains compliance throughout the product development lifecycle -providing sponsors with confidence in every regulatory touchpoint from first-in-human to commercialization.

Global Bridge offers expert pharmaceutical registration services across the EU, Asia Pacific, and the U.S., ensuring seamless regulatory navigation and market access. Our global team specializes in regional dossier preparation, agency liaison, and compliance with ICH, FDA, EMA, and local authority requirements. From strategic planning to submission and post-approval support, we accelerate timelines and reduce risk. Trust Global Bridge to bridge regulatory complexities and streamline your path to global drug approval.